Literature DB >> 22065675

HTLV-2 APH-2 expression is correlated with proviral load but APH-2 does not promote lymphocytosis.

Estelle Douceron1, Zhanna Kaidarova, Paola Miyazato, Masao Matsuoka, Edward L Murphy, Renaud Mahieux.   

Abstract

We recently discovered the antisense protein of human T-cell leukemia virus (HTLV) type 2 (APH-2), whose messenger RNA is encoded by the antisense strand of the HTLV-2 genome. We quantified proviral load, level of tax, and APH-2 in a series of blood samples obtained from a cohort of HTLV-2 carriers. We determined whether APH-2 promotes cell proliferation. APH-2 was detectable in most samples tested and was correlated with proviral load. APH-2 levels were not correlated with lymphocyte count in vivo, consistent with the inability of APH-2 to promote cell proliferation in vitro. APH-2 does not promote cell proliferation and does not cause lymphocytosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22065675      PMCID: PMC3242747          DOI: 10.1093/infdis/jir708

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

1.  Quantitation of HTLV-I and II proviral load using real-time quantitative PCR with SYBR Green chemistry.

Authors:  Tzong-Hae Lee; Daniel M Chafets; Michael P Busch; Edward L Murphy
Journal:  J Clin Virol       Date:  2004-12       Impact factor: 3.168

Review 2.  The epidemiology and disease outcomes of human T-lymphotropic virus type II.

Authors:  Diana F Roucoux; Edward L Murphy
Journal:  AIDS Rev       Date:  2004 Jul-Sep       Impact factor: 2.500

3.  The complementary strand of the human T-cell leukemia virus type 1 RNA genome encodes a bZIP transcription factor that down-regulates viral transcription.

Authors:  Gilles Gaudray; Frederic Gachon; Jihane Basbous; Martine Biard-Piechaczyk; Christian Devaux; Jean-Michel Mesnard
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

4.  HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells.

Authors:  Yorifumi Satou; Jun-ichirou Yasunaga; Mika Yoshida; Masao Matsuoka
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-09       Impact factor: 11.205

5.  Increased prevalence of infectious diseases and other adverse outcomes in human T lymphotropic virus types I- and II-infected blood donors. Retrovirus Epidemiology Donor Study (REDS) Study Group.

Authors:  E L Murphy; S A Glynn; J Fridey; R A Sacher; J W Smith; D J Wright; B Newman; J W Gibble; D I Ameti; C C Nass; G B Schreiber; G J Nemo
Journal:  J Infect Dis       Date:  1997-12       Impact factor: 5.226

6.  Long-term variations in human T lymphotropic virus (HTLV)-I and HTLV-II proviral loads and association with clinical data.

Authors:  Nicholas Kwaan; Tzong-Hae Lee; Daniel M Chafets; Catharie Nass; Bruce Newman; James Smith; George Garratty; Edward L Murphy
Journal:  J Infect Dis       Date:  2006-10-27       Impact factor: 5.226

7.  One-step, multiplex, real-time PCR assay with molecular beacon probes for simultaneous detection, differentiation, and quantification of human T-cell leukemia virus types 1, 2, and 3.

Authors:  Guillaume Besson; Mirdad Kazanji
Journal:  J Clin Microbiol       Date:  2009-02-11       Impact factor: 5.948

8.  Long-term increases in lymphocytes and platelets in human T-lymphotropic virus type II infection.

Authors:  Melissa T Bartman; Zhanna Kaidarova; Dale Hirschkorn; Ronald A Sacher; Joy Fridey; George Garratty; Joan Gibble; James W Smith; Bruce Newman; Anthony E Yeo; Edward L Murphy
Journal:  Blood       Date:  2008-08-28       Impact factor: 22.113

9.  HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivo.

Authors:  Yorifumi Satou; Jun-Ichirou Yasunaga; Tiejun Zhao; Mika Yoshida; Paola Miyazato; Ken Takai; Kei Shimizu; Koichi Ohshima; Patrick L Green; Naganari Ohkura; Tomoyuki Yamaguchi; Masahiro Ono; Shimon Sakaguchi; Masao Matsuoka
Journal:  PLoS Pathog       Date:  2011-02-10       Impact factor: 6.823

10.  In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).

Authors:  Mineki Saito; Toshio Matsuzaki; Yorifumi Satou; Jun-Ichirou Yasunaga; Kousuke Saito; Kimiyoshi Arimura; Masao Matsuoka; Yoshiro Ohara
Journal:  Retrovirology       Date:  2009-02-19       Impact factor: 4.602

View more
  19 in total

1.  Human T-cell leukemia virus type 2 antisense viral protein 2 is dispensable for in vitro immortalization but functions to repress early virus replication in vivo.

Authors:  Han Yin; Priya Kannian; Nathan Dissinger; Robyn Haines; Stefan Niewiesk; Patrick L Green
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

2.  Stability of HTLV-2 antisense protein is controlled by PML nuclear bodies in a SUMO-dependent manner.

Authors:  Louise Dubuisson; Florence Lormières; Stefania Fochi; Jocelyn Turpin; Amandine Pasquier; Estelle Douceron; Anaïs Oliva; Ali Bazarbachi; Valérie Lallemand-Breitenbach; Hugues De Thé; Chloé Journo; Renaud Mahieux
Journal:  Oncogene       Date:  2018-03-06       Impact factor: 9.867

3.  The ESCRT-0 Protein HRS Interacts with the Human T Cell Leukemia Virus Type 2 Antisense Protein APH-2 and Suppresses Viral Replication.

Authors:  Fanny Martini; Coline Arone; Amy Hasset; William W Hall; Noreen Sheehy
Journal:  J Virol       Date:  2019-12-12       Impact factor: 5.103

4.  Hyperediting of human T-cell leukemia virus type 2 and simian T-cell leukemia virus type 3 by the dsRNA adenosine deaminase ADAR-1.

Authors:  Nga Ling Ko; Emmanuel Birlouez; Simon Wain-Hobson; Renaud Mahieux; Jean-Pierre Vartanian
Journal:  J Gen Virol       Date:  2012-09-19       Impact factor: 3.891

5.  Human T-cell leukemia virus type 3 (HTLV-3) and HTLV-4 antisense-transcript-encoded proteins interact and transactivate Jun family-dependent transcription via their atypical bZIP motif.

Authors:  Émilie Larocque; Charlotte André-Arpin; Malgorzata Borowiak; Guy Lemay; William M Switzer; Madeleine Duc Dodon; Jean-Michel Mesnard; Benoit Barbeau
Journal:  J Virol       Date:  2014-05-28       Impact factor: 5.103

6.  Functional Comparison of HBZ and the Related APH-2 Protein Provides Insight into Human T-Cell Leukemia Virus Type 1 Pathogenesis.

Authors:  Amanda R Panfil; Nathan J Dissinger; Cory M Howard; Brandon M Murphy; Kristina Landes; Soledad A Fernandez; Patrick L Green
Journal:  J Virol       Date:  2016-01-27       Impact factor: 5.103

7.  Temporal regulation of HTLV-2 expression in infected cell lines and patients: evidence for distinct expression kinetics with nuclear accumulation of APH-2 mRNA.

Authors:  Cecilia Bender; Francesca Rende; Alessia Cotena; Paola Righi; Paola Ronzi; Ilaria Cavallari; Claudio Casoli; Vincenzo Ciminale; Umberto Bertazzoni
Journal:  Retrovirology       Date:  2012-09-13       Impact factor: 4.602

8.  The transcription profile of Tax-3 is more similar to Tax-1 than Tax-2: insights into HTLV-3 potential leukemogenic properties.

Authors:  Sébastien A Chevalier; Stéphanie Durand; Arindam Dasgupta; Michael Radonovich; Andrea Cimarelli; John N Brady; Renaud Mahieux; Cynthia A Pise-Masison
Journal:  PLoS One       Date:  2012-07-20       Impact factor: 3.240

9.  Interplay between the HTLV-2 Tax and APH-2 proteins in the regulation of the AP-1 pathway.

Authors:  Céline Marban; Aine McCabe; Terence N Bukong; William W Hall; Noreen Sheehy
Journal:  Retrovirology       Date:  2012-12-03       Impact factor: 4.602

10.  Functional comparison of antisense proteins of HTLV-1 and HTLV-2 in viral pathogenesis.

Authors:  Benoit Barbeau; Jean-Marie Peloponese; Jean-Michel Mesnard
Journal:  Front Microbiol       Date:  2013-08-07       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.